PHARMACEUTICAL COALTION FOR PATIENT ACCESS (EIN 883121489) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Principal Officer

KEVIN RIGBY

Phone

2012485172

Tax Period

2024-07-01 to 2025-06-30

PHARMACEUTICAL COALTION FOR PATIENT ACCESS, founded in 2022, is a micro nonprofit that reported $70 in total revenue in fiscal year 2024. Revenue fell 100% from the prior year — a significant decline worth monitoring. Expenses of $360K exceeded revenue, resulting in a 513771% operating deficit.

Mission

TO PROVIDE FINANCIAL ASSISTANCE TO LOW-INCOME MEDICARE PART D CANCER PATIENTS WITH THEIR PREVIOUSLY PRESCRIBED ONCOLOGY THERAPIES TO ENSURE PATIENTS LIVING WITH CANCER HAVE ACCESS TO ONCOLOGY MEDICINES PRESCRIBED BY THEIR HEALTH CARE PROVIDERS AND COVERED BY MEDICARE PART D.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $0

Other Revenue $70

TOTAL REVENUE $70

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $359,710

TOTAL EXPENSES $359,710

Year-over-Year Comparison

	2024	2023	Change
Revenue	$70	$700,000	-1.0%
Expenses	$359,710	$693,786	-0.5%
Net Income	$-359,640	$6,214	-58.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOSEPH JANELA	TREASURER	0.25	Director	$0	$0	$0
AL PARKER	SECRETARY	0.25	Director	$0	$0	$0
ELIZABETH A RYAN	VICE CHAIRMA	0.25	Director	$0	$0	$0
JOHN W TREECE	CHAIRMAN	4.00	Director	$0	$0	$0
LAURA JEANNE WEBER	TRUSTEE	1.00	Director	$0	$0	$0
NINA MYRL WEINBERG	TRUSTEE	0.25	Director	$0	$0	$0
KEVIN RIGBY	PRESIDENT	15.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$70	$359,710	$3,921	$-359,640
2025	No data	$3,921	No data	No data
2024	No data	No data	No data	No data
2023	$500,847	$143,500	$357,347	$357,347

PHARMACEUTICAL COALTION FOR PATIENT ACCESS